ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
191 hedge funds and large institutions have $2.56B invested in Array Biopharma Inc in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 28 closing their positions.
Holders
191
Holders Change
+7
Holders Change %
+3.8%
% of All Funds
4.34%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
35
Increased
75
Reduced
57
Closed
28
Calls
$44M
Puts
$22.5M
Net Calls
+$21.5M
Net Calls Change
+$20.1M
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$111M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$278M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$119M |
| 4 |
4
BlackRock
New York
|
$195M |
| 5 |
EC
5
EcoR1 Capital
San Francisco,
California
|
$36.9M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$97.6M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$73.1M |
| 3 |
PC
3
PointState Capital
New York
|
$5.25M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$17.3M |
| 5 |
5
Two Sigma Investments
New York
|
$13.7M |
